$13.7M cannabis net revenue, 183% increase over previous quarter, and 2,486% increase over prior year’s quarterPositive cash flow from operations85% gross margin on cannabis net revenue3% increase SG&A expenses over previous quarter$35M in cash, cash equivalents and marketable securitiesTotal liabilities decline by $7.9 million over Q4 2019Fifth consecutive quarter reporting record revenue, second consecutive quarter of positive adjusted EBITDAAdjusted EBITDA margin of 44%Cash cost to produce per gram of $0.31TORONTO, May 13, 2020 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), is pleased to report its financial results for the three months ended March 31, 2020 (“Q1 2020”).Management Commentary
Bay Street News